Skip to main content

Table 1 PI3K, p85 and p110 and mTOR Multivariate Analysis*

From: Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer

Marker

Relative

95% Confidence

P-value

 

Risk

Interval

  

PI3K - p85

1.026

[1.004

-

1.048]

 

0.02

PI3K - p110α

0.946

[0.872

-

1.025]

 

0.1762

mTOR

1.017

[0.992

-

1.042]

 

0.178

Stage

4.087

[2.120

-

5.469]

<

0.0001

Nuclear Grade

2.898

[1.536

-

5.469]

 

0.001

  1. *Statistically significant markers are bolded
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us